NuVue Therapeutics, Inc.

Home

Company

Milestones

Technologies

Enhanced Ultrasound

Microencapsulation

Cryothermal Effects

Diagnostic Products

ColorMark-A Biopsy Needle

ColorMark-C Biopsy Needle

BrightMark Tissue Markers

Therapeutic Products

ChemoAblator

CryoChemoAblator

NuVue Chemo

Management

Roger Kolasinski

James Stuber

James Kulinski

Patrick Le Pivert

Dennis Morrison

Mark Ehlert

News

510(k) Approval Received

Best Life Sciences Co

Contact

Legal

Roger Kolasinski

Roger Kolasinski, the Company’s founder and major shareholder, serves as its Chief Executive Officer.  A graduate of Michigan State University (1968) with a B.S. degree in microbiology, he began his career in the field of genetic research in the Microbiology Department at the University of Connecticut.  He then moved into specialty medical equipment sales, and in 1971 founded Kol Bio-Medical Instruments, Inc., which continues as one of the largest specialty distributorships in the U.S. medical marketplace.  Mr. Kolasinski sold his interest in Kol Bio-Medical in order to focus all of his efforts on NuVue.  Mr. Kolasinski brings to his leadership of the Company an unusual ability to realize sound technologies with a strong sell-in, arising from his strong bioengineering background and years of successful sales of specialty medical devices and therapeutics.  Mr. Kolasinski has remained active with Michigan State, serving on the Dean’s Board of Advisors of the University’s College of Natural Science. 
NuVue Therapeutics, Inc.  Copyright 2011.  All rights reserved.

Website powered by Network Solutions®